Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Total worldwide generic prescription drug revenue 2010-2024

Worldwide total generic prescription drug revenue from 2010 to 2024 (in billion U.S. dollars)

by Matej Mikulic, last edited Jun 18, 2019
Total worldwide generic prescription drug revenue 2010-2024 This statistic depicts the total generic prescription drug revenue worldwide from 2010 to 2024. In 2019, the industry is expected to generate 79 billion U.S. dollars in generic prescription drug revenue worldwide. Until 2024, the global prescribed generics market is expected to reach 100 billion U.S. dollars. Generics are much cheaper copies of originally branded drugs which lost their patent protection. Through the use of generics instead of branded/patent protected drugs, savings of many billions of dollars can be achieved.
Show more

Worldwide total generic prescription drug revenue from 2010 to 2024 (in billion U.S. dollars)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Related Studies: Available to Download in PDF or PPTX Format
Generics and biosimilars
Generics and biosimilars

All Information
in one Presentation

Generics and biosimilars

Everything On "Generics and biosimilars" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Generics and biosimilars"
  • Global overview
The most important statistics
  • Top companies
  • U.S. market
  • Patent expiration
  • Savings
  • Biosimilars
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.